Medication info
Ultra Newsemi Tablet

Ultra Newsemi Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
Sears Pharmaceutical Co., Ltd.
Appearance
Pale yellow oblong film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202004095 · Approved 2020.05.29 · Insurance code 689001350

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
The dose should be adjusted according to the patient's pain severity and response to treatment. Administer the lowest effective dose for the shortest possible period. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 16 tablets per day.

Ingredients

Manufacturer
Sears Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

The dose should be adjusted according to the patient's pain severity and response to treatment. Administer the lowest effective dose for the shortest possible period. Do not administer this medicine for longer than necessary. If long-term administration is required due to the nature and severity of the disease, conduct regular monitoring to determine whether treatment with this medicine should be continued. Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years and older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment For patients with moderate hepatic impairment, carefully consider extending the dosing interval. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, allow an interval of at least 6 hours between doses, and do not exceed 16 tablets per day.

Precautions

This medication may burden the liver, so individuals who consume a significant amount of alcohol daily should consult a physician or pharmacist before use. If a rash or allergic reaction occurs during treatment, discontinue use immediately and consult a healthcare professional. Caution is required in patients with a history of seizures or those taking medications that can induce seizures, as there is a risk of seizures. Serious allergic reactions can occur occasionally; immediate emergency treatment is necessary for symptoms such as difficulty breathing or severe rash. Patients with severe respiratory conditions may experience difficulty breathing when taking this medication and should do so under medical supervision. Concurrent use with alcohol or central nervous system depressants may result in severe drowsiness or respiratory suppression; therefore, coadministration should be avoided or approached with caution. If there is a history of head injury or brain disease, there is a risk of increased intracranial pressure when taking this medication, so caution is advised. This medication may cause physical and psychological dependence; therefore, dependency should be monitored with long-term use. Patients with impaired liver function must consult a physician before taking this medication and should be careful not to exceed the recommended dosage. Patients with certain genetic metabolic characteristics may experience excessive effects of this medication, leading to risks of respiratory suppression, so they should consult a healthcare professional. This medication should not be used in children under 12 years of age or in certain pediatric patients following specific surgeries; it should also be avoided in adolescents over 12 years of age if special risk factors are present. Patients with sleep apnea or hypoxemia should be closely monitored as this medication may worsen symptoms. Elderly patients or patients at risk of hyponatremia should monitor for the occurrence of hyponatremia while taking this medication. Individuals allergic to the ingredients of this medication, those in severe respiratory suppression, those with head trauma, or those taking specific medications should not take this medication. Sudden discontinuation during treatment may cause withdrawal symptoms; therefore, dosage should be gradually reduced according to a physician's instructions. This medication may cause drowsiness or dizziness when driving or operating machinery, so caution is needed. In the event of an overdose, serious respiratory suppression, seizures, and liver damage may occur; therefore, adherence to the prescribed dosage is crucial, and in case of overdose, medical attention should be sought immediately. Keep this medication out of reach of children, and limit access to prevent misuse or abuse.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disturbances, confusion, disorientation, agitation, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraines, hypersomnia, sensory loss, tremors, sensory disturbances, attention deficit, fainting, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, visual blurring, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, muscle weakness, chest pain, emotional abnormality, chills, chest discomfort, malaise, withdrawal syndrome from medication, thirst, irritability, feeling of warmth, weight loss, increased serum creatinine, anaphylaxis reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal thoughts, muscular hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hyponatremia, fixed rash, muscle weakness, fever, edema, rigidity, fainting, congestive heart failure, dizziness, confusion, worsening migraines, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function tests, oliguria, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of stomach cancer, paralytic ileus, hiccups, cholecystitis, insomnia, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, palpitations, arrhythmias, worsening hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, vomiting, dyspepsia, abdominal pain, constipation, dry mouth, diarrhea, hiccups, paralytic ileus, cholecystitis, abnormal kidney function tests, increased salivation, gastrointestinal bleeding, drowsiness, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, palpitations, hypertension, arrhythmias, tachycardia, worsening hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, weight loss, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, dizziness, fever, edema, chest pain, rigidity, fainting, congestive heart failure, confusion, migraines, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, belching, discomfort in the chest

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent exposure to air or moisture and keep it at room temperature between 1°C and 30°C. This way of storage will help maintain the medication's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.